Sharp Corp. buy krebskrebs
Start price
17.05.22
/
50%
€1.88
Target price
17.05.23
€2.20
Performance (%)
-24.47%
End price
18.05.23
€1.42
Summary
This prediction ended on 18.05.23 with a price of €1.42. The prediction for Sharp Corp. disappointed with a performance of -24.47%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sharp Corp. | - | - | - | - |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
Comments by krebskrebs for this prediction
In the thread Sharp Corp. diskutieren
In the thread Trading Sharp Corp.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten